Logo for Compass Therapeutics Inc

Compass Therapeutics Investor Relations Material

Latest events

Logo for Compass Therapeutics Inc

Study Result

Compass Therapeutics
Logo for Compass Therapeutics

Q3 2024

12 Nov, 2024
Logo for Compass Therapeutics

Q2 2024

12 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Compass Therapeutics Inc

Access all reports
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics primarily targeting oncology. The company’s research centers on the interaction between angiogenesis, the immune system, and tumor growth. Its pipeline includes novel therapeutic candidates designed to modulate key biological pathways to elicit an effective anti-tumor response. This includes strategies to influence the tumor microvasculature, activate immune cells, and overcome immunosuppressive mechanisms employed by tumors. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.